Global Uranium Corp. Announces Amendment to LIFE Offering for C$1,500,000
Globenewswire· 2025-09-17 20:15
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | FRA: Q3J) (the “Company”) announces, that it has amended the terms of its previously announced financing under the Listed Issuer Financing Exemption (the “Offering”) to increase the minimum amount to be raised under the Offering to C$1,500,000. Under the Offering, as amended, the Company intends to complete a non-brokered pri ...
NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1
Globenewswire· 2025-09-17 20:15
Data show a favorable safety profile and early efficacy signals in a heavily pre-treated population whose cancer progressed after multiple prior lines of therapy including anti-PD-1Recommended phase 2 dose (RP2D) established at 33% of gross tumor volume (GTV)47.4% (9/19) best observed objective response rate (ORR) in all lesions per RECIST 1.178.9% (15/19) best observed disease control rate (DCR) in all lesions per RECIST 1.114.6 months median Overall Survival (mOS) in all patients treated (n=21)Investigato ...
Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM
Globenewswire· 2025-09-17 20:15
CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that 48-week clinical data from the Phase 3 study in China evaluating telitacicept in adults with generalized myasthenia gravis, a study sponsored by Vor’s collaborator RemeGen Co., Ltd (HKEX: 9995, SHA: 688331), will be presented as an oral presentation at the American Association of Neuromuscular & Electrodiagnostic Medicine A ...
CooperCompanies Announces Expanded Share Repurchase Program
Globenewswire· 2025-09-17 20:15
SAN RAMON, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today its Board of Directors has approved a $1 billion increase in the Company’s share repurchase program. The share repurchase program now totals $2 billion. “We are pleased to announce that our Board of Directors has authorized an increase to our share repurchase program,” said Al White, President and Chief Executive Officer. “This decision underscores the strength of our ...
Regional Health Properties, Inc. Completes Repurchases of 12.5% Series B Cumulative Redeemable Preferred Shares
Globenewswire· 2025-09-17 20:08
Atlanta, GA, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB) (OTCQB: RHEPZ) today announced it has completed the repurchase of 366,359 shares of its 12.5% Series B Cumulative Redeemable Preferred shares through three privately negotiated transactions. “The recently closed merger with SunLink Health Systems was a transformative step for Regional Health Properties. We are excited to use a portion of the excess cash obtained in the me ...
FRO – Filing of Half Yearly Report
Globenewswire· 2025-09-17 20:07
Frontline plc (the “Company”) announces the filing of its half yearly report for the six months ended June 30, 2025. The half yearly report can be downloaded from the Company’s website www.frontlineplc.cy or from the link below. September 17, 2025Frontline plcLimassol, Cyprus. Questions should be directed to: Lars H. Barstad: Chief Executive Officer, Frontline Management AS+47 23 11 40 00 Inger M. Klemp: Chief Financial Officer, Frontline Management AS+47 23 11 40 00 This information is subject to the discl ...
Fidelity D & D Bancorp, Inc. Announces Retirement of Director Richard Hotchkiss
Globenewswire· 2025-09-17 20:07
DUNMORE, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) (“Fidelity Bank”), the parent bank holding company of The Fidelity Deposit and Discount Bank (“Fidelity Bank”), a Pennsylvania state-chartered, FDIC-insured community bank and trust company headquartered in Dunmore, PA, announces the retirement of Director Richard Hotchkiss effective September 16th, 2025. Mr. Hotchkiss was appointed to the Fidelity Bank Board of Directors on May 5, 2020, following the merger with MN ...
Nano Dimension Announces Financial Results for the Second Quarter 2025
Globenewswire· 2025-09-17 20:05
WALTHAM, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension”, “Nano”, or the “Company”), a leader in digital manufacturing solutions, today announced financial results for the second quarter ended June 30, 2025. The consolidated results incorporate the financial position and performance of Markforged Holding Corporation (“Markforged”) from the acquisition date of April 25, 2025, inclusive of revenue of $16.1 million, gross profit of $3.4 million and GAAP net loss o ...
Globus Maritime Sets Date for the Release of Second Quarter and First Half 2025 Results
Globenewswire· 2025-09-17 20:05
GLYFADA, Greece, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Globus Maritime Limited (the “Company” or "Globus") (NASDAQ: GLBS), a dry bulk shipping company, announced today that it will release financial results for the quarter and six-month period ended June 30, 2025, after the market closes in New York on Friday, September 19, 2025. About Globus Maritime Limited Globus is an integrated dry bulk shipping company that provides marine transportation services worldwide. The Company’s operating fleet consists of nine ...
XPO Schedules Third Quarter 2025 Earnings Conference Call for Thursday, October 30, 2025
Globenewswire· 2025-09-17 20:05
GREENWICH, Conn., Sept. 17, 2025 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO) will hold its third quarter conference call and webcast on Thursday, October 30, at 8:30 a.m. Eastern Time. The company's results will be released earlier that morning and made available on www.xpo.com. Access information:Call toll-free from US/Canada: 1-877-269-7756International callers: +1-201-689-7817Live webcast online at: www.xpo.com/investors A replay of the conference call will be available until November 29, 2025, by calling toll- ...